Buys
Open market- Shares
- Avg price
- Total value
Sherry Korczynski - Chief Commercial Officer at Aquestive Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Commercial Officer
- Issuer ticker
- AQST on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Sherry Korczynski in Aquestive Therapeutics, Inc.
Sells
Open market- Shares
- -15,741
- Avg price
- $4.17
- Total value
- -$65,687
Net
Past year- Shares
- -15,741
- Share %
- -100%
- Total value
- -$65,687
Reported holdings for Sherry Korczynski in Aquestive Therapeutics, Inc.
Form 4 holding
Chief Commercial Officer
Aquestive Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 238,403
- Estimated value
- $989,372
- Report date
- 08 Jun 2026
- Price
- $4.15
- Ownership
- Direct
Form 4 holding
Chief Commercial Officer
Aquestive Therapeutics, Inc.
- Security class
- Performance Stock Units
- Shares / value
- 67,500
- Estimated value
- Report date
- 07 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Commercial Officer
Aquestive Therapeutics, Inc.
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 42,500
- Estimated value
- Report date
- 09 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Sherry Korczynski in Aquestive Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.